Geopolitical Tensions Escalate Putin Vows Retaliation After Ukraine Strike on Russian Drone Unit US Plans Ebola Treatment Facility in Kenya Raising Health Security and Fiscal Questions Enhanced Games Backed by Donald Trump Jr and Peter Thiel Steroid Olympics Set for Sunday Debut CPF LIFE vs SelfInvesting The Critical Factor of Financial Management in Retirement Wall Street Edges Higher as Healthcare and Tech Lead Dow Outperforms Amazon Expands AI Shopping Technology to ThirdParty Retailers Signs Kate Spade as Customer FWRD Q1 2026 Earnings EPS Misses Estimates Amidst Operational Headwinds PASG Q1 2026 Earnings Narrowerthanexpected loss lifts shares Vishay Precision Group Inc VPG Q1 2026 Earnings EPS Surpasses Expectations on Operational Discipline SBCF Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations First Merchants Corporation Depository Shares FRMEP Q1 2026 Earnings EPS Beats Estimates by 895 Amid Stable Market Conditions Biglari Holdings Q1 2025 Earnings Strong EPS Performance Amid Limited Visibility Eve Holding Inc EVEX Edges Higher as Shares Test Key Resistance at 32 Colony Bankcorp CBAN Edges Lower as Shares Approach Key Support Level Redwood Trust Senior Notes RWTP Slide Marginally as Yield Attracts Cautious Traders Rezolve AI Warrants RZLVW Edge Higher Navigating Support and Resistance Levels Cytokinetics CYTK Edges Higher as Shares Test Key Resistance Zone OXSQG Q1 2026 Earnings EPS Misses Estimates as Investment Income Declines Shares Edge Higher LIC Shares Rise After Strong Quarterly Performance Analyst Revises Target Price OpenAI Takes Early Lead in AI IPO Race Confidential Filing Expected This Week NDAQ Q1 2026 Earnings EPS Beats Estimates by 111 Revenue Not Disclosed Shares Edge Higher UFPT Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher MIR Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Unavailable China Industrial Profits Surge 247 in April Fastest Gain Since Late 2023 NeoVolta NEOV Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence Stock Drops 2364 Sagimet Biosciences SGMT Edges Higher as Clinical Momentum Builds